Also Announces Change to Unaudited Financial Results Released March 18,
FT. MYERS, Fla., April 15 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that it had filed with the Securities and Exchange Commission its annual report on Form 10-KSB for the year ended December 31, 2007. A copy of this annual report can be found at http://www.SEC.gov .
The audited financial statements for the year ended December 31, 2007 included in the 10-KSB included an additional contingency charge expense of approximately $177,000 versus the unaudited results we issued on March 18, 2008. This contingency charge was for registration penalties we have been incurring as a result of delays in completing an effective registration statement for the shares we sold in our June 2007 private placement. In accordance with FASB Staff Position 00-19-2, "Accounting for Registration Payment Arrangements", we have accrued approximately $177,000 of penalty expense as of December 31, 2007 for the liquidated damages expected through May 2008. As a result of this change, our audited net loss for FY 2007 has increased by $177,000 versus the net loss we issued in our March 18, 2008 earnings release. However, by taking a charge for this in 2007, we hope to avoid any further negative impacts to our income statement from these penalties in 2008.
About NeoGenomics, Inc.
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical
laboratory that specializes in cancer genetics diagnostic testing, the
fastest growing segment of the laboratory industry. The company's testing
services include cytogenetics, fluorescence in-situ hybridization (FISH),
flow cytometry, morphology studies, anatomic pathology and molecular
genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in
Nashville, TN, Irvine, CA and Fort Myers and services the needs of
|SOURCE NeoGenomics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved